Hospira Barred from Launching Lexiscan Generic until Oct. 5: Astellas

Astellas Pharma said on September 26 that it has won an interim injunction from a US district court enjoining Hospira from rolling out a generic version of the Japanese company’s pharmacologic stress agent Lexiscan (regadenoson) until October 5. The interim...read more